Hints and tips:
Related Special Reports
...Blade signed up high-profile early investors including IAC’s Barry Diller and David Zaslav, now CEO of Warner Bros Discovery Networks. It raised $365mn by going public last year....
...In 2019, Namal Nawana, an Australian who had worked in the US, quit as chief executive of Smith & Nephew because the UK medical devices company could not meet his pay demands....
...The Barry Silbert-backed platform was last year forced to amend “misleading” posters plastered around London bearing the slogan “If you’re seeing Bitcoin on the Underground, it’s time to buy”....
...Citigroup has hired Barry Weir, a JPMorgan Chase veteran known for working on mining deals, as a managing director in London, according to an internal memo seen by DD....
...DS Smith has appointed former Unilever chief financial officer Alan Johnson to its board as a non-executive director....
...Brad Smith, Microsoft president, said the company was partly at fault, without pointing to specifics....
...That’s a shame — as it does little to neutralise the tendency to “negligence and profusion” that Smith worried about....
...Those last allegations are almost certainly false, not least because the Duke of Clarence was in fact taking his nephews to a PizzaExpress at the time of the killings....
...She succeeds Barry Meyers, who is leaving for a job outside banking....
...An internal memo written by Microsoft president Brad Smith and sent to staff in June outlined the company’s strategy....
...Eddie Hearn, the British boxing promoter who is taking over his father Barry’s business, has said of Succession: “It’s just like us!”...
...Job moves Danone has chosen Antoine de Saint-Affrique, who has run Swiss cocoa and chocolate manufacturer Barry Callebaut since 2015, as its chief executive....
...Smith & Nephew has held talks to buy NuVasive, a maker of medical instruments used in spinal surgery, in a deal that would be worth more than $3bn and mark the largest acquisition by the British medical...
...Smith+Nephew, the orthopaedic device maker, said it expects a fourth quarter underlying revenue decline of approximately 7 per cent....
...Smith & Nephew goes up to “overweight” at Morgan Stanley. A V-shaped recovery in kneecaps isn’t in the price, they say....
...Smith & Nephew “lowers growth outlook amid coronavirus uncertainty” and its shares are up more than 8 per cent....
...Of the large-cap health stocks, Vermeer Partners, another London-based wealth manager, favours medical device stocks Zimmer Biomet and Smith & Nephew, given that demand for elective surgery has been deferred...
...But in his 18-month stint at Smith & Nephew, Mr Nawana oversaw a 40 per cent increase in its share price....
...US outfits such as Cadwalader, Wickersham & Taft, Reed Smith, BCLP and Baker McKenzie have moved swiftly to cut both payouts for partners and salaries for more junior lawyers — going further than most UK...
...FTSE 100 group Smith & Nephew had an even worse April than ITV. April revenues for the medical devices maker dropped 47 per cent, as elective surgeries have come to a halt in many countries....
...The lockdowns imposed to contain the virus are likely to have hit sales of drugs that need a doctor to administer them, while the delay in non-essential surgeries has hurt others including Smith & Nephew...
...Luckily DD’s Rob Smith goes into the details behind the demand....
...Namal Nawana: competitive spirit UK medical devices maker Smith & Nephew seems keen to shift its listing to the US. That would give it a freer rein to raise the pay of chief exec Namal Nawana....
...Smith & Nephew states that ‘multiple [UK] private hospital groups [are] aiming for late June to restart’ – this is in line with our expectations given that the 14-week NHS deal started 30 March....
...Xerox wants to give HP’s board its walking papers We’re all guilty of overusing the David v Goliath trope but in the case of Xerox and HP, it really does apply....
International Edition